Business

Update on International Expansion

Update on International Expansion.

articleCrimson Tide PlcFebruary 2, 20175/company/crimson-tide-plc/news/update-on-international-expansion
Update on International Expansion

About this update from Crimson Tide Plc

[{"type":"text","content":"\n \nRNS Number : 8077V Crimson Tide PLC 02 February 2017  \n\nCrimson Tide PLC\n(\"Crimson Tide\" or the 'Company')\nUpdate on International Expansion \n \nCrimson Tide (AIM: TIDE), provider of mpro5, Smart Mobility as a Service, is pleased to update the market on its progress with international expansion. As announced in the Company's Trading Update on 14 December 2016, we have begun to invest in international expansion following the success of our partnership in Ireland. Similar to our model in Ireland, the strategic emphasis is on initiating growth through collaborative partnerships with known third parties, where there is a clear demand for mpro5, thereby creating considerable potential with limited risk. As such, the following developments are being put in place:\n \n·     Western Europe - Erik-Jan Smulders has been appointed to expand the Company's sales footprint in the region. Previously with BlackBerry, Erik has significant experience in growing businesses across Europe, Middle East and Asia ('EMEA') in both the Small Medium Business (\"SMB\") and Enterprise markets, both through channel and direct sales.\n \n·     UAE - The Company has signed an agreement with BCB (British Centres for Business) in Dubai, to take advantage of its Incubator Programme. BCB will focus on the setup of Crimson Tide's Dubai office and UAE business through the introduction to potential partners. Additionally, their role is to act as facilitator by introducing mpro5 to key emerging verticals in this region; namely Facilities Management and Health. \n \n·     United States - Crimson Tide will shortly join RX360, the trade organisation which includes 18 of the world's top 20 pharmaceutical companies and many of their global suppliers. This follows introductions from RX360 to APEC Business Advisory Council in the US, as well as other pharma businesses where mpro5 is currently in the pilot/early implementation stages. RX360's mission is to promote patient safety by improving the integrity of the Healthcare supply chain; an area where mpro5 has an important role to play.  As a result, Crimson Tide is likely to open a small representative office in the coming months.\n \n·     Australia - The Company has entered into a Memorandum of Und...

More updates from Crimson Tide Plc